Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.35B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.1B |
| 3 |
Apple
AAPL
|
+$556M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$488M |
| 5 |
Coca-Cola
KO
|
+$464M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.15B |
| 3 |
Microsoft
MSFT
|
+$777M |
| 4 |
McDonald's
MCD
|
+$585M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$549M |
Sector Composition
| 1 | Technology | 16.54% |
| 2 | Healthcare | 16.17% |
| 3 | Consumer Discretionary | 11.83% |
| 4 | Financials | 10.91% |
| 5 | Industrials | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Albemarle Corp Depositary Shares
ALB.PRA
$1.6B
| – | – |
0
| – | -$88.4M |
|
427
Moderna
MRNA
$9.52B
| $54.7M | 0.01% |
460,456
+188,119
| +69% | +$22.3M |
|
428
BridgeBio Pharma
BBIO
$10.2B
| $54.6M | 0.01% |
2,156,449
+1,273,174
| +144% | +$32.2M |
|
|
GAP
429
The Gap, Inc.
GAP
$8.94B
| $54.4M | 0.01% |
2,276,780
+202,990
| +10% | +$4.85M |
|
|
PYCR
430
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $54.4M | 0.01% |
4,280,087
+472,644
| +12% | +$6M |
|
431
Mirum Pharmaceuticals
MIRM
$3.9B
| $54.2M | 0.01% |
1,585,624
+193,118
| +14% | +$6.6M |
|
432
Merit Medical Systems
MMSI
$5.43B
| $54.2M | 0.01% |
630,405
+342,222
| +119% | +$29.4M |
|
433
Diamondback Energy
FANG
$39.5B
| $54.2M | 0.01% |
+270,611
| New | +$54.2M |
|
434
Enbridge
ENB
$105B
| $54.1M | 0.01% |
1,520,230
+242,029
| +19% | +$8.61M |
|
435
Take-Two Interactive
TTWO
$45.7B
| $53.9M | 0.01% |
346,947
+346,756
| +181,548% | +$53.9M |
|
436
Enliven Therapeutics
ELVN
$1.17B
| $53.9M | 0.01% |
2,307,814
-46,589
| -2% | -$1.09M |
|
437
JD.com
JD
$48B
| $53.9M | 0.01% |
2,086,335
-787,767
| -27% | -$20.4M |
|
438
Freeport-McMoran
FCX
$63B
| $53.7M | 0.01% |
1,105,243
-781,544
| -41% | -$38M |
|
439
Abercrombie & Fitch
ANF
$4.48B
| $53.7M | 0.01% |
301,939
-170,938
| -36% | -$30.4M |
|
440
Insmed
INSM
$31.1B
| $53.6M | 0.01% |
799,746
-127,817
| -14% | -$8.56M |
|
441
Flex
FLEX
$21B
| $53.6M | 0.01% |
1,816,366
-3,014,353
| -62% | -$88.9M |
|
442
First Interstate BancSystem
FIBK
$3.41B
| $53.5M | 0.01% |
1,927,294
+723,002
| +60% | +$20.1M |
|
443
Globus Medical
GMED
$7.98B
| $53.4M | 0.01% |
780,328
+208,399
| +36% | +$14.3M |
|
444
IBM
IBM
$241B
| $53.3M | 0.01% |
308,173
-106,041
| -26% | -$18.3M |
|
445
Cencora
COR
$57.9B
| $53M | 0.01% |
235,336
-72,607
| -24% | -$16.4M |
|
446
Caterpillar
CAT
$196B
| $52.2M | 0.01% |
+156,780
| New | +$52.2M |
|
447
IDEAYA Biosciences
IDYA
$2.17B
| $51.9M | 0.01% |
1,479,323
+47,877
| +3% | +$1.68M |
|
448
Travel + Leisure Co
TNL
$4.04B
| $51.6M | 0.01% |
1,147,412
+1,130,604
| +6,727% | +$50.9M |
|
449
Nucor
NUE
$32.4B
| $51.6M | 0.01% |
326,170
-101,203
| -24% | -$16M |
|
450
T-Mobile US
TMUS
$273B
| $51.4M | 0.01% |
291,832
+139,215
| +91% | +$24.5M |
|